CN100377752C - 带血管定位和防护装置的多功能智能数字激光治疗仪 - Google Patents
带血管定位和防护装置的多功能智能数字激光治疗仪 Download PDFInfo
- Publication number
- CN100377752C CN100377752C CNB2005101344854A CN200510134485A CN100377752C CN 100377752 C CN100377752 C CN 100377752C CN B2005101344854 A CNB2005101344854 A CN B2005101344854A CN 200510134485 A CN200510134485 A CN 200510134485A CN 100377752 C CN100377752 C CN 100377752C
- Authority
- CN
- China
- Prior art keywords
- laser
- target vessel
- casing
- location
- irradiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 47
- 210000004369 blood Anatomy 0.000 title abstract description 59
- 239000008280 blood Substances 0.000 title abstract description 59
- 239000004973 liquid crystal related substance Substances 0.000 claims abstract description 8
- 210000004204 blood vessel Anatomy 0.000 claims description 18
- 238000012545 processing Methods 0.000 claims description 17
- 210000001595 mastoid Anatomy 0.000 claims description 9
- 230000003287 optical effect Effects 0.000 claims description 7
- 210000001367 artery Anatomy 0.000 claims description 5
- 230000006698 induction Effects 0.000 claims description 5
- 230000010349 pulsation Effects 0.000 claims description 5
- 239000004568 cement Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 230000008685 targeting Effects 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 21
- 238000013461 design Methods 0.000 abstract description 15
- 206010020772 Hypertension Diseases 0.000 abstract description 9
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract description 8
- 208000018262 Peripheral vascular disease Diseases 0.000 abstract description 8
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract description 8
- 201000001421 hyperglycemia Diseases 0.000 abstract description 4
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract description 3
- 230000001678 irradiating effect Effects 0.000 abstract 2
- 230000007774 longterm Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 83
- 208000024172 Cardiovascular disease Diseases 0.000 description 28
- 230000002526 effect on cardiovascular system Effects 0.000 description 27
- 210000002321 radial artery Anatomy 0.000 description 22
- 108010007622 LDL Lipoproteins Proteins 0.000 description 17
- 102000007330 LDL Lipoproteins Human genes 0.000 description 17
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 230000006872 improvement Effects 0.000 description 15
- 208000031226 Hyperlipidaemia Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 14
- 210000003743 erythrocyte Anatomy 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 208000029078 coronary artery disease Diseases 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 108010010234 HDL Lipoproteins Proteins 0.000 description 9
- 102000015779 HDL Lipoproteins Human genes 0.000 description 9
- 206010008132 Cerebral thrombosis Diseases 0.000 description 8
- 108010023302 HDL Cholesterol Proteins 0.000 description 8
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 8
- 108010028554 LDL Cholesterol Proteins 0.000 description 8
- 230000002776 aggregation Effects 0.000 description 8
- 238000004220 aggregation Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 102000008946 Fibrinogen Human genes 0.000 description 6
- 108010049003 Fibrinogen Proteins 0.000 description 6
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 241000135309 Processus Species 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 229940012952 fibrinogen Drugs 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000004065 semiconductor Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 210000003484 anatomy Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000036770 blood supply Effects 0.000 description 5
- 206010008118 cerebral infarction Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 208000013220 shortness of breath Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000000707 wrist Anatomy 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 206010040007 Sense of oppression Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 3
- 238000002647 laser therapy Methods 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 210000003928 nasal cavity Anatomy 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000931526 Acer campestre Species 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- 206010006100 Bradykinesia Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004134 energy conservation Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000024806 Brain atrophy Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 208000026344 Nasal disease Diseases 0.000 description 1
- 208000030880 Nose disease Diseases 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 201000006559 Vertebrobasilar insufficiency Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 201000002676 cerebral atherosclerosis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000001951 hemoperfusion Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- -1 lecithin cholesterol fatty acid Chemical class 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000013546 non-drug therapy Methods 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 208000004124 rheumatic heart disease Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Radiation-Therapy Devices (AREA)
Abstract
Description
N ValldMeanStd.Error of MeanMedianStd.DeviationSkewnessStd.Error of SkewnessKurtosisStd.Error of KurtosisRangeMinimumMaximum | 3429.06.139.002.37.411.132-.262.26310515 |
分组 | 例数(n) | 显效(n,%) | 有效(n,%) | 无效(n,%) | 总有效率(n,%) |
对照组实验组 | 3233 | 11(34.38%)19(57.58%) | 13(40.62%)12(36.36%) | 8(25.00%)2(6.06%) | 24(75.00%)31(93.94%)* |
组别 | 例数n | 总胆固醇(TC) | 甘油三脂(TG) | 低密度脂蛋白(LDL-C) | 高密度脂蛋白(HDL-C) |
对照组实验组 | 治疗前32治疗后32治疗前33治疗后33 | 8.06±1.735.82±1.46*8.42±1.555.18±1.62**▲▲ | 2.87±0.661.73±0.48*2.94±0.691.58±0.65*▲ | 5.07±0.853.58±0.67*5.28±0.942.81±0.72**▲▲ | 1.07±0.481.11±0.27***1.02±0.361.56±0.43*▲▲ |
病种 | 例数(n) | 显效n(%) | 有效n(%) | 无效n(%) | 总有效率n(%) |
心血管病组脑血管病组周围血管病组代谢综合症组总计 | 37331535120 | 22(59.46%)18(54.55%)8(53.33%)19(54.29%)67(55.83%) | 13(35.13%)12(36.36%)5(33.33%)13(37.14%)43(35.83%) | 2(5.41%)3(9.09%)2(13.33%)3(8.57%)10(8.33%) | 35(94.59%)30(90.91%)13(86.67%)32(91.43%)110(91.67%) |
检查项目 | 单位 | 治疗前 | 治疗后 | T值 | P值 |
全血比粘度低切全血比粘度高切血浆粘度红细胞压积红细胞聚集指数纤维蛋白原 | MPa/smPa/smPa/sL/L-g/L | 19.24±0.595.30±0.881.75±0.470.49±1.216.43±0.774.07±0.91 | 17.11±0.684.31±0.741.68±0.550.42±1.174.69±0.623.88±0.74 | 6.182.412.943.735.463.55 | <0.01<0.05<0.05<0.01<0.01<0.05 |
项目 | 单位 | 治疗前 | 治疗后 | t值 | P值 |
总胆固醇(TC)甘油三脂(TG)低密脂蛋白(LDL-C)高密脂蛋白(HDL-C) | mmol/Lmmol/Lmmol/Lmmol/L | 8.08±1.232.21±0.444.25±0.381.42±0.20 | 5.42±1.141.66±0.623.36±0.271.74±0.3l | 3.652.242.861.53 | <0.01<0.05<0.01<0.05 |
项目 | 单位 | 治疗前 | 治疗后 | t值 | P值 |
血糖(TC)糖化血红蛋白(GSP) | mmol/Lmmol/L | 7.72±1.552.93±1.04 | 6.13±1.422.36±0.95 | 4.172.86 | <0.05<0.05 |
积分值 | 治疗前 | 治疗后 | ||
一个疗程 | 二个疗程 | 三个疗程 | ||
管袢形态血液流态袢周形态总积分值 | 1.78±0.352.62±0.421.47±0.295.87±0.53 | 1.55±0.28*1.43±0.36*1.44±0.184.42±0.44* | 1.24±0.21**1.06±0.29**1.27±0.21*3.57±0.64** | 1.12±0.19**0.69±0.23**1.01±0.17*2.82±0.64** |
症状 | 发生例数 | 发生率 | 改善例数 | 改善率 |
头晕心悸胸闷气短胸痛疲倦乏力腰膝酸软反应迟钝肢体麻木记忆力减退 | 986285418031251642 | 81.66%51.66%70.83%34.17%66.67%25.83%20.83%13.33%35.00% | 945577337626181035 | 95.92%88.71%90.59%80.49%95.00%83.87%72.00%62.50%83.33% |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101344854A CN100377752C (zh) | 2005-12-15 | 2005-12-15 | 带血管定位和防护装置的多功能智能数字激光治疗仪 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101344854A CN100377752C (zh) | 2005-12-15 | 2005-12-15 | 带血管定位和防护装置的多功能智能数字激光治疗仪 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1785453A CN1785453A (zh) | 2006-06-14 |
CN100377752C true CN100377752C (zh) | 2008-04-02 |
Family
ID=36783123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101344854A Expired - Fee Related CN100377752C (zh) | 2005-12-15 | 2005-12-15 | 带血管定位和防护装置的多功能智能数字激光治疗仪 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100377752C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104548384A (zh) * | 2014-12-18 | 2015-04-29 | 岑志勇 | 光子经前综合征治疗仪 |
CN113952624A (zh) * | 2021-10-16 | 2022-01-21 | 武汉左点科技有限公司 | 一种三高治疗仪激光定位方法及装置 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2351137Y (zh) * | 1998-10-09 | 1999-12-01 | 郑跃连 | 定向定位光针 |
CN1354030A (zh) * | 2001-12-12 | 2002-06-19 | 岑志勇 | 半导体激光血疗仪 |
CN2535056Y (zh) * | 2002-03-29 | 2003-02-12 | 华南师范大学 | 半导体激光辐照血液治疗仪 |
CN1528478A (zh) * | 2003-10-13 | 2004-09-15 | 遂 纪 | 微型腕式半导体激光治疗仪 |
WO2005004704A2 (en) * | 2003-07-08 | 2005-01-20 | Light Sciences Corporation | Light generating device that self centers within a lumen to render photodynamic therapy |
-
2005
- 2005-12-15 CN CNB2005101344854A patent/CN100377752C/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2351137Y (zh) * | 1998-10-09 | 1999-12-01 | 郑跃连 | 定向定位光针 |
CN1354030A (zh) * | 2001-12-12 | 2002-06-19 | 岑志勇 | 半导体激光血疗仪 |
CN2535056Y (zh) * | 2002-03-29 | 2003-02-12 | 华南师范大学 | 半导体激光辐照血液治疗仪 |
WO2005004704A2 (en) * | 2003-07-08 | 2005-01-20 | Light Sciences Corporation | Light generating device that self centers within a lumen to render photodynamic therapy |
CN1528478A (zh) * | 2003-10-13 | 2004-09-15 | 遂 纪 | 微型腕式半导体激光治疗仪 |
Also Published As
Publication number | Publication date |
---|---|
CN1785453A (zh) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9603774B2 (en) | Evidence-based acupuncture and moxibustion meridian-acupoint treating and detecting instrument supporting multiplexed output and method of use thereof | |
TW202310798A (zh) | 具生理參數監測之穿戴裝置 | |
CN112716471A (zh) | 用于评估血管重建的***和方法 | |
CN101743035B (zh) | 预防和治疗慢性伤口的低频电刺激装置 | |
JP7234352B2 (ja) | 痛風及び疼痛の治療装置 | |
CN100377752C (zh) | 带血管定位和防护装置的多功能智能数字激光治疗仪 | |
CN110180085B (zh) | 一种直插式半导体红光***鼻炎辅助光疗仪 | |
CN101085396A (zh) | 一种激光照射桡动脉、静脉和/内关穴的治疗仪 | |
WO2018059177A1 (zh) | 移动式癫痫病治疗仪及癫痫病治疗*** | |
WO2024013267A1 (en) | Wearable and automated ultrasound therapy devices and methods | |
CN201529331U (zh) | 腕踝两用激光、磁场血液治疗仪 | |
Plank et al. | The effectiveness of acupuncture for chronic daily headache: an outcomes study | |
CN102770179A (zh) | 光治疗装置 | |
KR102249554B1 (ko) | 통합 면역 암치료를 위한 환자 맞춤형 치료 시스템 | |
Belavskaya et al. | Some actual problems of electronic instrument in the field of reflexotherapy | |
Stakhanov et al. | Thermometric control of phototherapeutic procedures | |
CN209575543U (zh) | 一种用于治疗痛风及疼痛的超声治疗装置 | |
CN2870896Y (zh) | 激光治疗仪的靶血管照射定位装置 | |
EP4138644A1 (en) | Systems and methods for managing a person's position to encourage proning | |
CN207237086U (zh) | 一种关节护理仪 | |
CN202724483U (zh) | 带尺动脉照射的激光治疗仪 | |
CN103566484A (zh) | 带尺动脉照射的激光治疗仪 | |
CN204502153U (zh) | 手心治疗仪及手部治疗仪 | |
Lazar et al. | Patient-centered Outcomes for Individuals with a Venous Leg Ulcer: A Scoping Review | |
Grey | Distribution of treatment time in physiotherapeutic application of ultrasound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Zhengzhou Bangtai Biotechnology Co. Ltd. Assignor: Lin Ping Contract fulfillment period: 2008.10.26 to 2014.10.25 Contract record no.: 2009410000001 Denomination of invention: Multifunction intelligent digital laser therapeutic instrument having blood ressel location and protection device Granted publication date: 20080402 License type: Exclusive license Record date: 20090106 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.10.26 TO 2014.10.25; CHANGE OF CONTRACT Name of requester: ZHENG ZHOU BANGTAI BIOTECHNOLOGY CO., LTD. Effective date: 20090106 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080402 |
|
CF01 | Termination of patent right due to non-payment of annual fee |